Hypertension News

• NKF 2025 Chlorthalidone Increases Kidney Stone Recurrence A secondary analysis of the DCP shows that, compared with hydrochlorothiazide, chlorthalidone significantly increases the risk of kidney stones — but only among those with prior stones.
  Medscape Medical News, April 11, 2025
• Consider Salt Sensitivity in Women’s Midlife Hypertension Some data suggest women get more sensitive to salt in their late 40s around the menopausal transition.
  Medscape Medical News, April 11, 2025
• Cardiac Dysfunction Surfaces Early With Cancer Treatment Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.
  Medscape Medical News, April 10, 2025
• Hypertensive Pregnancy Increases Dilated Cardiomyopathy Risk Hypertensive disorders of pregnancy in first pregnancies double the risk for dilated cardiomyopathy, with the onset earlier than that in normotensive pregnancies.
  Medscape News UK, April 08, 2025
• ACC 2025 WARRIOR Underscores Burden of Nonobstructive Angina in Women Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high rate of hospitalization in this population, which is not well understood.
  Medscape Medical News, April 04, 2025
• Tips for PCPs on Addressing and Preventing Heart Disease Cardiac illnesses are among the trickier ones to manage in the limited time provided for many primary care visits, with common and easily dismissed symptoms often providing early signs of disease.
  Medscape Medical News, April 03, 2025
• Obesity ‘Strongly’ Linked to 16 Cardiometabolic Diseases The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep apnea, among others, increases with increasing BMI.
  Medscape Medical News, April 02, 2025
• Thyroid Dysfunction Can Damage Kidneys in Kids With Obesity Children with obesity and subclinical hypothyroidism have twice the risk for kidney damage compared with those without subclinical hypothyroidism, a retrospective study shows.
  Medscape News UK, April 01, 2025
• Early Statin Use Shows Sustained Cardiovascular Benefits Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year follow-up study reveals.
  Medscape News UK, April 01, 2025
• ACC 2025 New Smartwatch Metric Points to Overall Heart Health A Northwestern medical student has found a better way of measuring heart health by smartwatch using a formula of steps per day and heart rate data.
  Medscape Medical News, March 29, 2025
• Alert Benefits Outweigh Risks for Weight Loss Drug Mysimba The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term cardiovascular safety, the EMA says.
  Medscape Medical News, March 28, 2025
• How T2D Patients With Albuminuria Respond to Dapagliflozin? In patients with type 2 diabetes and albuminuria, dapagliflozin leads to a significant reduction in urine albumin-to-creatinine ratio, but with considerable variability in response among individuals.
  Medscape News UK, March 27, 2025
• ACC 2025 BP Below 130 mm Hg Linked to CV Benefit in Octogenarians A systolic BP level below 130 mm Hg is associated with a lower risk for cardiovascular mortality than 130-160 mm Hg in adults older than 80 years taking antihypertensive medications.
  Medscape Medical News, March 26, 2025
• Cancer Survivors Show Unique CVD Patterns Cancer survivors have an elevated risk for cardiovascular diseases, with variations by cancer type and ethnicity.
  Medscape News UK, March 24, 2025
• Physicians Welcome Testosterone Labeling Changes Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be removed, the FDA announced.
  Medscape Medical News, March 18, 2025
• Risk Model Validates Finerenone Effect in Heart Failure The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.
  Medscape News UK, March 18, 2025
• ECIM 2025 Almost Half of Hypertension Patients Don’t Know They Have It With hypertension affecting 1.3 billion people worldwide, experts stress that poor diagnosis and treatment adherence continue to hinder efforts to reduce cardiovascular risk.
  Medscape Medical News, March 13, 2025
• Positive Topline Results for Lorundrostat in Hypertension Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and resistant hypertension.
  Medscape Medical News, March 12, 2025
• BP Patterns and Adverse Outcomes in Gestational Hypertension An increasing diastolic blood pressure pattern is associated with an elevated risk for adverse maternal outcomes in late gestational hypertension.
  Medscape News UK, March 11, 2025
• GLP-1 RAs Cut Cardiovascular Risk in Metabolic Liver Disease A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events and mortality in patients with MASLD.
  Medscape Medical News, March 06, 2025